Skip to main content

Advertisement

Log in

Validation of the Mexican Spanish Version of the EORTC QLQ-H&N35 Instrument to Measure Health-related Quality of Life in Patients with Head and Neck Cancers

  • Healthcare Policy and Outcomes
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Health-related quality of life (HRQL) is an important outcome measurement in oncology. Our aim was to validate the Mexican Spanish version of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-H&N35 questionnaire to measure HRQL in patients with head and neck cancers.

Methods

The QLQ-C30 and QLQ-H&N35 instruments were applied to Mexican patients with head and neck cancer at a cancer referral center. Reliability and validity tests were performed. Test–retest was carried out in selected patients.

Results

One hundred ninety-three patients were included in this cohort; tumor locations included the following: oral cavity 45 (23.3 %); larynx 35 (18.1 %); thyroid carcinoma invasive to aerodigestive tract 32 (16.6 %); oropharynx 17 (8.8 %); hypopharynx 12 (6.2 %); nasal cavity and paranasal sinuses 11 (5.7 %); salivary glands 11 (5.7 %); nasopharynx 8 (4.1 %); eye and adnexa 7 (3.6 %); cervical metastases of unknown origin 5 (2.6 %); primary sarcoma of the head and neck region 5 (2.6 %); maxillary antrum carcinoma 4 (2.1 %); and retinoblastoma 1 (0.5 %). Questionnaire compliance rates were high, and the instrument was well accepted; the internal consistency tests demonstrated good convergent and divergent validity. Cronbach’s α coefficients of 8 of 9 multi-item scales of the QLQ-C30 and 6 of 8 scales of the QLQ-H&N35 instruments were >0.7 (range 0.22–0.89). Scales of the QLQ-C30 and QLQ-H&N35 instruments distinguished among clinically distinct groups of patients; some were highly sensitive to change over time.

Conclusions

The Mexican Spanish version of the QLQ-H&N35 questionnaire is reliable and valid for the assessment of HRQL in patients with head and neck cancers and can be used in clinical trials in Mexican communities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008: Cancer incidence and mortality worldwide. IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr.

  2. Verdonck-de Leeuw IM, van Nieuwenhuizen A, Leemans CR. The value of quality-of-life questionnaires in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2012;20:142–7.

  3. Brizel DM, Lydiatt W, Colevas AD. Controversies in the locoregional management of head and neck cancer. J Natl Compr Canc Netw. 2011;9:653–62.

    PubMed  Google Scholar 

  4. Tschudi D, Stoeckli S, Schmid S. Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope. 2003;113:1949–54.

    Article  PubMed  Google Scholar 

  5. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.

    Article  PubMed  CAS  Google Scholar 

  6. Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients: EORTC Quality of Life Study Group. Acta Oncol. 1994;33:879–85.

    Article  PubMed  CAS  Google Scholar 

  7. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire–H&N35. J Clin Oncol. 1999;17:1008–19.

    PubMed  CAS  Google Scholar 

  8. Bjordal K, de Graeff A, Fayers PM, et al. A 12-country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36:1796–807.

    Article  PubMed  CAS  Google Scholar 

  9. Jensen K, Jensen AB, Grau C. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish. Acta Oncol. 2006;45:28–37.

    Article  PubMed  Google Scholar 

  10. Yang Z, Meng Q, Luo J, et al. Development and validation of the simplified Chinese version of EORTC QLQ-H&N35 for patients with head and neck cancer. Support Care Cancer. 2012;20:1555–64.

    Google Scholar 

  11. Chie WC, Hong RL, Lai CC, Ting LL, Hsu MM. Quality of life in patients of nasopharyngeal carcinoma: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Qual Life Res. 2003;12:93–8.

    Article  PubMed  CAS  Google Scholar 

  12. Tschiesner U, Rogers SN, Harréus U, Berghaus A, Cieza A. Content comparison of quality of life questionnaires used in head and neck cancer based on the International Classification of Functioning, Disability and Health: a systematic review. Eur Arch Otorhinolaryngol. 2008;265:627–37.

    Article  PubMed  CAS  Google Scholar 

  13. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A; American Joint Committee on Cancer. AJCC cancer staging manual. 7th edition. New York: Springer; 2010.

  14. Oñate-Ocaña LF, Alcántara-Pilar A, Vilar-Compte D, et al. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer. Ann Surg Oncol. 2009;16:88–95.

    Article  PubMed  Google Scholar 

  15. Koller M, Aaronson NK, Blazeby JM, et al. Translation procedures for standardized quality of life questionnaires: The European Organization for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer. 2007;43:1810–20.

    Article  PubMed  Google Scholar 

  16. Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 scoring manual. 3rd edition. Brussels, Belgium: European Organisation for Research and Treatment of Cancer; 2001.

    Google Scholar 

  17. Tabachnik BJ, Fidell LS. Using multivariate statistics. London: Harper & Row; 1993.

    Google Scholar 

  18. Fayers PM, Machin D. Quality of life: assessment, analysis and interpretation. 2nd edition. London: Wiley; 2007.

    Google Scholar 

  19. Nalbadian M, Nikolaidis V, Nikolaou A, Themelis C, Kouloulas A, Vital V. Psychometric properties of the EORTC head and neck—specific quality of life questionnaire in disease-free Greek patients with cancer of pharynx and larynx. Qual Life Res. 2010;19:761–8.

    Article  PubMed  Google Scholar 

  20. Bower WF, Vlantis AC, Chung TM, Cheung SK, Bjordal K, van Hasselt CA. Quality of life in head and neck cancer patients after surgical resection: translation into Cantonese and validation of the EORTC QLQ-H&N35. Acta Otolaryngol. 2009;129:779–85.

    Article  PubMed  CAS  Google Scholar 

  21. Sherman AC, Simonton S, Adams DC, Vural E, Owens B, Hanna E. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck Module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg. 2000;126:459–67.

    PubMed  CAS  Google Scholar 

  22. McNair AG, Brookes ST, Davis CR, Argyropoulos M, Blazeby JM. Communicating the results of randomized clinical trials: do patients understand multidimensional patient-reported outcomes? J Clin Oncol. 2010;28:738–43.

    Article  PubMed  Google Scholar 

  23. Quinten C, Coens C, Mauer M, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009;10:865–71.

    Article  PubMed  Google Scholar 

  24. Nibu K, Ebihara Y, Ebihara M, et al. Quality of life after neck dissection: a multicenter longitudinal study by the Japanese Clinical Study Group on standardization of treatment for lymph node metastasis of head and neck cancer. Int J Clin Oncol. 2010;15:33–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the European Organisation for Research and Treatment of Cancer Quality of Life Group, particularly Linda Dewolf, for their extensive support in the translation procedures of the QLQ-H&N35 questionnaires. We thank Maggie Brunner, MA, for English-language editorial review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luis F. Oñate-Ocaña MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carrillo, J.F., Ortiz-Toledo, M.Á., Salido-Noriega, Z. et al. Validation of the Mexican Spanish Version of the EORTC QLQ-H&N35 Instrument to Measure Health-related Quality of Life in Patients with Head and Neck Cancers. Ann Surg Oncol 20, 1417–1426 (2013). https://doi.org/10.1245/s10434-012-2712-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2712-9

Keywords

Navigation